Revolution Medicines (RVMD) SVP & GC Jeff Cislini Sells Shares

What Happened

• Jeff Cislini, SVP & General Counsel of Revolution Medicines (RVMD), sold a total of 3,366 shares on 2026-09-16. The sales consisted of 52 shares at a weighted average price of $195.01 (proceeds $10,140) and 3,314 shares at $199.30 (proceeds $660,491), for total gross proceeds of approximately $670,631. These transactions were sales (not purchases).

Key Details

• Transaction date: 2026-09-16; filing date: 2026-09-18.
• Sales: 52 shares @ $195.01 (weighted avg); 3,314 shares @ $199.30.
• Total shares sold: 3,366; total proceeds: ~$670,631.
• Footnotes: Transactions were made pursuant to a Rule 10b5-1 instruction adopted May 31, 2023 to satisfy tax withholding on RSU vesting. One sale was executed in multiple trades at prices ranging $195.00–$195.03 (weighted avg reported). Filing notes inclusion of 37,088 restricted stock units.
• Shares owned after transaction: the filing excerpt references 37,088 RSUs per footnote; total post-transaction beneficial ownership is not specified in the provided excerpt.
• Filing timeliness: filed two days after the trade (no indication in the excerpt that the filing was late).

Context

• These sales were executed under a pre-established 10b5-1 plan to cover tax withholding related to RSU vesting; such transactions are typically routine and do not by themselves indicate the insider’s view on the company’s outlook.